Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

Phase I study of pentosan polysulfate in cancer patients

Feb. 25, 1997

Positive clinical results for doxazosin as BPH Rx

Feb. 21, 1997

Centocor seeks expansion of ReoPro indications

Feb. 21, 1997

Transdermal buspirone pivotal trials

Feb. 21, 1997

Schering-Plough seeks FDA approval for psoriasis treatment

Feb. 20, 1997

Antidepressant with minimal impact on sexual function introduced

Feb. 18, 1997

Immunomedics' LeukoScan approved for European market

Feb. 18, 1997

New dosage strengths of Coumadin available

Feb. 18, 1997

Japanese introduction for new formulation of epoetin alfa

Feb. 18, 1997

Harvard Scientific's impotence drug advances in European trials

Feb. 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...